Friday, December 11, 2020

CG Oncology Finds $47M More

Irvine-based CG Oncology, a biopharmaceuticals company which focuses on cancer therapy, said that it has raised $47M in a Series D financing round. The funding was led by Kissei Pharmaceutical Co., Ltd.,and also included ORI Healthcare Fund, Camford Capital and Perseverance Capital Management. The company said the funding goes towards its lead oncolyt

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.

---